MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors

Molecular Oncology

Volumn 10, Issue 9, 2016, Pages 1387-1403

  Geekiyanage, Hirosha ^a   Galanis, Evanthia ^a  

^a MAYO CLINIC   (United States)

Author keywords

Breast cancer; Glioblastoma; Measles virus; miRNA; Ovarian cancer; PVRL4

Indexed keywords

MICRORNA; MICRORNA 128; MICRORNA 31; POLIOVIRUS RECEPTOR RELATED 4; UNCLASSIFIED DRUG; VIRUS RECEPTOR; CELL ADHESION MOLECULE; LNIR PROTEIN, HUMAN; MESSENGER RNA; MIRN128 MICRORNA, HUMAN; MIRN31 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MEASLES; MEASLES VIRUS; MOUSE; NEOPLASM; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; TUMOR VOLUME; TUMOR XENOGRAFT; VIRUS INFECTIVITY; VIRUS STRAIN; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOGENICITY; PATHOLOGY; TUMOR CELL LINE; VIROLOGY;

ANIMALS; BASE SEQUENCE; CELL ADHESION MOLECULES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEASLES VIRUS; MICE, NUDE; MICRORNAS; NEOPLASMS; RNA, MESSENGER; TUMOR BURDEN;

EID: 85014129759     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2016.07.007     Document Type: Article

References (111)

1. Albrecht, P., Lorenz, D., Klutch, M.J., Vickers, J.H., Ennis, F.A., Fatal measles infection in marmosets pathogenesis and prophylaxis. Infect. Immun. 27 (1980), 969–978.
2. Ambros, V., The evolution of our thinking about microRNAs. Nat. Med. 14 (2008), 1036–1040.
3. Ameres, S.L., Zamore, P.D., Diversifying microRNA sequence and function. Nat. Rev. Mol. Cell Biol. 14 (2013), 475–488.
4. Amiel, J., de Pontual, L., Henrion-Caude, A., miRNA, development and disease. Adv. Genet. 80 (2012), 1–36.
5. Augoff, K., McCue, B., Plow, E.F., Sossey-Alaoui, K., miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol. Cancer, 11, 2012, 5.
6. Baertsch, M.A., Leber, M.F., Bossow, S., Singh, M., Engeland, C.E., Albert, J., Grossardt, C., Jager, D., von Kalle, C., Ungerechts, G., MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus. Cancer Gene Ther. 21 (2014), 373–380.
7. Banno, K., Yanokura, M., Iida, M., Adachi, M., Nakamura, K., Nogami, Y., Umene, K., Masuda, K., Kisu, I., Nomura, H., Kataoka, F., Tominaga, E., Aoki, D., Application of microRNA in diagnosis and treatment of ovarian cancer. Biomed. Res. Int., 2014, 2014, 232817.
8. Barnes, D., Kunitomi, M., Vignuzzi, M., Saksela, K., Andino, R., Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe 4 (2008), 239–248.
9. Berezikov, E., Evolution of microRNA diversity and regulation in animals. Nat. Rev. Genet. 12 (2011), 846–860.
10. Betel, D., Koppal, A., Agius, P., Sander, C., Leslie, C., Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol., 11, 2010, R90.
11. Blenkiron, C., Goldstein, L.D., Thorne, N.P., Spiteri, I., Chin, S.F., Dunning, M.J., Barbosa-Morais, N.L., Teschendorff, A.E., Green, A.R., Ellis, I.O., Tavare, S., Caldas, C., Miska, E.A., MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol., 8, 2007, R214.
12. Bluming, A.Z., Ziegler, J.L., Regression of Burkitt's lymphoma in association with measles infection. Lancet 2 (1971), 105–106.
13. Buck, A.H., Perot, J., Chisholm, M.A., Kumar, D.S., Tuddenham, L., Cognat, V., Marcinowski, L., Dolken, L., Pfeffer, S., Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection. RNA 16 (2010), 307–315.
14. Cazalla, D., Yario, T., Steitz, J.A., Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science 328 (2010), 1563–1566.
15. Chang, T.H., Huang, H.Y., Hsu, J.B., Weng, S.L., Horng, J.T., Huang, H.D., An enhanced computational platform for investigating the roles of regulatory RNA and for identifying functional RNA motifs. BMC Bioinform., 14(Suppl. 2), 2013, S4.
16. Ciafre, S.A., Galardi, S., Mangiola, A., Ferracin, M., Liu, C.G., Sabatino, G., Negrini, M., Maira, G., Croce, C.M., Farace, M.G., Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. 334 (2005), 1351–1358.
17. Clemmons, N.S., Gastanaduy, P.A., Fiebelkorn, A.P., Redd, S.B., Wallace, G.S., Measles – United States, January 4-April 2, 2015. MMWR Morb. Mortal. Wkly. Rep. 64 (2015), 373–376.
18. Creighton, C.J., Fountain, M.D., Yu, Z., Nagaraja, A.K., Zhu, H., Khan, M., Olokpa, E., Zariff, A., Gunaratne, P.H., Matzuk, M.M., Anderson, M.L., Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res. 70 (2010), 1906–1915.
19. Croce, C.M., Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10 (2009), 704–714.
20. Dahiya, N., Morin, P.J., MicroRNAs in ovarian carcinomas. Endocr. Relat. Cancer 17 (2010), F77–F89.
21. de Swart, R.L., Measles studies in the macaque model. Curr. Top. Microbiol. Immunol. 330 (2009), 55–72.
22. Delpeut, S., Noyce, R.S., Richardson, C.D., The tumor-associated marker, PVRL4 (Nectin-4), is the epithelial receptor for morbilliviruses. Viruses-Basel 6 (2014), 2268–2286.
23. DeRycke, M.S., Pambuccian, S.E., Gilks, C.B., Kalloger, S.E., Ghidouche, A., Lopez, M., Bliss, R.L., Geller, M.A., Argenta, P.A., Harrington, K.M., Skubitz, A.P.N., Nectin 4 overexpression in ovarian cancer tissues and serum. Am. J. Clin. Pathol. 134 (2010), 835–845.
24. Dong, Q., Cai, N., Tao, T., Zhang, R., Yan, W., Li, R., Zhang, J., Luo, H., Shi, Y., Luan, W., Zhang, Y., You, Y., Wang, Y., Liu, N., An axis involving SNAI1, microRNA-128 and SP1 modulates glioma progression. PLoS One, 9, 2014, e98651.
25. Dorig, R.E., Marcil, A., Chopra, A., Richardson, C.D., The human Cd46 molecule is a receptor for measles-virus (Edmonston strain). Cell 75 (1993), 295–305.
26. Erlenhoefer, C., Wurzer, W.J., Loffler, S., Schneider-Schaulies, S., Ter Meulen, V., Schneider-Schaulies, J., CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J. Virol. 75 (2001), 4499–4505.
27. Fabre-Lafay, S., Garrido-Urbani, S., Reymond, N., Goncalves, A., Dubreuil, P., Lopez, M., Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM-17. J. Biol. Chem. 280 (2005), 19543–19550.
28. Fabre-Lafay, S., Monville, F., Garrido-Urbani, S., Berruyer-Pouyet, C., Ginestier, C., Reymond, N., Finetti, P., Sauvan, R., Adelaide, J., Geneix, J., Lecocq, E., Popovici, C., Dubreuil, P., Viens, P., Goncalves, A., Charafe-Jauffret, E., Jacquemier, J., Birnbaum, D., Lopez, M., Nectin-4 is a new histological and serological tumor associated marker for breast cancer. BMC Cancer, 7, 2007.
29. Fu, X.P., Rivera, A., Tao, L.H., De Geest, B., Zhang, X.L., Construction of an oncolytic herpes simplex virus that precisely targets hepatocellular carcinoma cells. Mol. Ther. 20 (2012), 339–346.
30. Geekiyanage, H., Chan, C., MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer's disease. J. Neurosci. 31 (2011), 14820–14830.
31. Gottwein, E., Cullen, B.R., Viral and cellular MicroRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 3 (2008), 375–387.
32. Guidi, M., Muinos-Gimeno, M., Kagerbauer, B., Marti, E., Estivill, X., Espinosa-Parrilla, Y., Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells. BMC Mol. Biol., 11, 2010, 95.
33. He, L., Hannon, G.J., MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet., 5, 2004, 522.
34. Iankov, I.D., Allen, C., Federspiel, M.J., Myers, R.M., Peng, K.W., Ingle, J.N., Russell, S.J., Galanis, E., Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus. Mol. Ther. 20 (2012), 1139–1147.
35. Institute, M.C.A.N.C., MV-NIS infected mesenchymal stem cells in treating patients with recurrent ovarian Cancer. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-[2014 May 13]. Available from: https://clinicaltrials.gov/ct2/show/NCT02068794 NLM Identifier: NCT02068794.
36. Institute, M.C.A.N.C., Recombinant measles virus vaccine therapy and oncolytic virus therapy in treating patients with progressive, recurrent, or refractory ovarian epithelial cancer or primary peritoneal cancer. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-[2014 May 13]. Available from: https://clinicaltrials.gov/ct2/show/NCT00408590 NLM Identifier: NCT00390299.
37. Institute, M.C.A.N.C., Viral therapy in treating patients with recurrent glioblastoma multiforme. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-[2014 May 13]. Available from: https://clinicaltrials.gov/ct2/show/NCT00390299 NLM Identifier: NCT00390299.
38. Iorio, M.V., Ferracin, M., Liu, C.G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., Menard, S., Palazzo, J.P., Rosenberg, A., Musiani, P., Volinia, S., Nenci, I., Calin, G.A., Querzoli, P., Negrini, M., Croce, C.M., MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65 (2005), 7065–7070.
39. Jopling, C.L., Yi, M., Lancaster, A.M., Lemon, S.M., Sarnow, P., Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309 (2005), 1577–1581.
40. Karsy, M., Arslan, E., Moy, F., Current progress on understanding microRNAs in glioblastoma multiforme. Genes Cancer 3 (2012), 3–15.
41. Kent, W.J., Sugnet, C.W., Furey, T.S., Roskin, K.M., Pringle, T.H., Zahler, A.M., Haussler, D., The human genome browser at UCSC. Genome Res. 12 (2002), 996–1006.
42. Kobune, F., Takahashi, H., Terao, K., Ohkawa, T., Ami, Y., Suzaki, Y., Nagata, N., Sakata, H., Yamanouchi, K., Kai, C., Nonhuman primate models of measles. Lab. Anim. Sci. 46 (1996), 315–320.
43. Koressaar, T., Remm, M., Enhancements and modifications of primer design program Primer3. Bioinformatics 23 (2007), 1289–1291.
44. Korner, C., Keklikoglou, I., Bender, C., Worner, A., Munstermann, E., Wiemann, S., MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKCepsilon). J. Biol. Chem. 288 (2013), 8750–8761.
45. Kotani, A., Ha, D., Schotte, D., den Boer, M.L., Armstrong, S.A., Lodish, H.F., A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 acute lymphocytic leukemia cells. Cell Cycle 9 (2010), 1037–1042.
46. Leber, M.F., Bossow, S., Leonard, V.H., Zaoui, K., Grossardt, C., Frenzke, M., Miest, T., Sawall, S., Cattaneo, R., von Kalle, C., Ungerechts, G., MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism. Mol. Ther. 19 (2011), 1097–1106.
47. Lee, C.Y.F., Rennie, P.S., Jia, W.W.G., MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells. Clin. Cancer Res. 15 (2009), 5126–5135.
48. Lee, E.J., Baek, M., Gusev, Y., Brackett, D.J., Nuovo, G.J., Schmittgen, T.D., Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA 14 (2008), 35–42.
49. Lee, S.T., Chu, K., Im, W.S., Yoon, H.J., Im, J.Y., Park, J.E., Park, K.H., Jung, K.H., Lee, S.K., Kim, M., Roh, J.K., Altered microRNA regulation in Huntington's disease models. Exp. Neurol. 227 (2011), 172–179.
50. Leonard, V.H., Hodge, G., Reyes-Del Valle, J., McChesney, M.B., Cattaneo, R., Measles virus selectively blind to signaling lymphocytic activation molecule (SLAM; CD150) is attenuated and induces strong adaptive immune responses in rhesus monkeys. J. Virol. 84 (2010), 3413–3420.
51. Lewis, B.P., Burge, C.B., Bartel, D.P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005), 15–20.
52. Liu, X., Gu, X., Sun, L., Flowers, A.B., Rademaker, A.W., Zhou, Y., Kiyokawa, H., Downregulation of Smurf2, a tumor-suppressive ubiquitin ligase, in triple-negative breast cancers: involvement of the RB-microRNA axis. BMC Cancer, 14, 2014, 57.
53. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001), 402–408.
54. Lou, W., Chen, Q., Ma, L., Liu, J., Yang, Z., Shen, J., Cui, Y., Bian, X.W., Qian, C., Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model. J. Mol. Med. (Berl) 91 (2013), 715–725.
55. Lu, J., Getz, G., Miska, E.A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B.L., Mak, R.H., Ferrando, A.A., Downing, J.R., Jacks, T., Horvitz, H.R., Golub, T.R., MicroRNA expression profiles classify human cancers. Nature 435 (2005), 834–838.
56. Lukiw, W.J., Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 18 (2007), 297–300.
57. Luna, J.M., Scheel, T.K., Danino, T., Shaw, K.S., Mele, A., Fak, J.J., Nishiuchi, E., Takacs, C.N., Catanese, M.T., de Jong, Y.P., Jacobson, I.M., Rice, C.M., Darnell, R.B., Hepatitis C virus RNA functionally sequesters miR-122. Cell 160 (2015), 1099–1110.
58. Masri, S., Liu, Z., Phung, S., Wang, E., Yuan, Y.C., Chen, S., The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells. Breast Cancer Res. Treat. 124 (2010), 89–99.
59. Mazzacurati, L., Marzulli, M., Reinhart, B., Miyagawa, Y., Uchida, H., Goins, W.F., Lil, A., Kaur, B., Caligiuri, M., Cripe, T., Chiocca, E.A., Amankulor, N., Cohen, J.B., Glorioso, J.C., Grandi, P., Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSV. Mol. Ther., 23, 2015, 99 215–215.
60. Mizoguchi, M., Guan, Y., Yoshimoto, K., Hata, N., Amano, T., Nakamizo, A., Sasaki, T., MicroRNAs in human malignant gliomas. J. Oncol., 2012, 2012, 732874.
61. Msaouel, P., Opyrchal, M., Musibay, E.D., Galanis, E., Oncolytic measles virus strains as novel anticancer agents. Expert Opin. Biol. Ther. 13 (2013), 483–502.
62. Muhlebach, M.D., Mateo, M., Sinn, P.L., Prufer, S., Uhlig, K.M., Leonard, V.H., Navaratnarajah, C.K., Frenzke, M., Wong, X.X., Sawatsky, B., Ramachandran, S., McCray, P.B. Jr., Cichutek, K., von Messling, V., Lopez, M., Cattaneo, R., Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 480 (2011), 530–533.
63. Nakamura, T., Russell, S.J., Oncolytic measles viruses for cancer therapy. Expert Opin. Biol. Ther. 4 (2004), 1685–1692.
64. Naniche, D., Variorkrishnan, G., Cervoni, F., Wild, T.F., Rossi, B., Rabourdincombe, C., Gerlier, D., Human membrane cofactor protein (Cd46) acts as a cellular receptor for measles-virus. J. Virol. 67 (1993), 6025–6032.
65. Network, C.G.A.R., Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455 (2008), 1061–1068.
66. Noyce, R.S., Bondre, D.G., Ha, M.N., Lin, L.T., Sisson, G., Tsao, M.S., Richardson, C.D., Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog., 7, 2011, e1002240.
67. Noyce, R.S., Richardson, C.D., Nectin 4 is the epithelial cell receptor for measles virus. Trends Microbiol. 20 (2012), 429–439.
68. Nuovo, G., Lee, E.J., Lawler, S., Godlewski, J., Schmittgen, T., In situ detection of mature microRNAs by labeled extension on ultramer templates. Biotechniques 46 (2009), 115–126.
69. Parsons, D.W., Jones, S., Zhang, X., Lin, J.C., Leary, R.J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.M., Gallia, G.L., Olivi, A., McLendon, R., Rasheed, B.A., Keir, S., Nikolskaya, T., Nikolsky, Y., Busam, D.A., Tekleab, H., Diaz, L.A. Jr., Hartigan, J., Smith, D.R., Strausberg, R.L., Marie, S.K., Shinjo, S.M., Yan, H., Riggins, G.J., Bigner, D.D., Karchin, R., Papadopoulos, N., Parmigiani, G., Vogelstein, B., Velculescu, V.E., Kinzler, K.W., An integrated genomic analysis of human glioblastoma multiforme. Science 321 (2008), 1807–1812.
70. Pavlova, N.N., Pallasch, C., Elia, A.E., Braun, C.J., Westbrook, T.F., Hemann, M., Elledge, S.J., A role for PVRL4-driven cell-cell interactions in tumorigenesis. Elife, 2, 2013, e00358.
71. Perry, R.T., Gacic-Dobo, M., Dabbagh, A., Mulders, M.N., Strebel, P.M., Okwo-Bele, J.M., Rota, P.A., Goodson, J.L., Progress toward regional measles elimination–worldwide, 2000–2013. MMWR Morb. Mortal. Wkly. Rep. 63 (2014), 1034–1038.
72. Peruzzi, P., Bronisz, A., Nowicki, M.O., Wang, Y., Ogawa, D., Price, R., Nakano, I., Kwon, C.H., Hayes, J., Lawler, S.E., Ostrowski, M.C., Chiocca, E.A., Godlewski, J., MicroRNA-128 coordinately targets polycomb repressor complexes in glioma stem cells. Neuro Oncol. 15 (2013), 1212–1224.
73. Phuong, L.K., Allen, C., Peng, K.W., Giannini, C., Greiner, S., TenEyck, C.J., Mishra, P.K., Macura, S.I., Russell, S.J., Galanis, E.C., Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme. Cancer Res. 63 (2003), 2462–2469.
74. Plumet, S., Gerlier, D., Optimized SYBR green real-time PCR assay to quantify the absolute copy number of measles virus RNAs using gene specific primers. J. Virol. Methods 128 (2005), 79–87.
75. Pratakpiriya, W., Seki, F., Otsuki, N., Sakai, K., Fukuhara, H., Katamoto, H., Hirai, T., Maenaka, K., Techangamsuwan, S., Lan, N.T., Takeda, M., Yamaguchi, R., Nectin4 is an epithelial cell receptor for canine distemper virus and involved in neurovirulence. J. Virol. 86 (2012), 10207–10210.
76. Qian, P., Banerjee, A., Wu, Z.S., Zhang, X., Wang, H., Pandey, V., Zhang, W.J., Lv, X.F., Tan, S., Lobie, P.E., Zhu, T., Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cells. Cancer Res. 72 (2012), 6036–6050.
77. Rajbhandari, R., McFarland, B.C., Patel, A., Gerigk, M., Gray, G.K., Fehling, S.C., Bredel, M., Berbari, N.F., Kim, H., Marks, M.P., Meares, G.P., Sinha, T., Chuang, J., Benveniste, E.N., Nozell, S.E., Loss of tumor suppressive microRNA-31 enhances TRADD/NF-kappaB signaling in glioblastoma. Oncotarget 6 (2015), 17805–17816.
78. Randall, G., Panis, M., Cooper, J.D., Tellinghuisen, T.L., Sukhodolets, K.E., Pfeffer, S., Landthaler, M., Landgraf, P., Kan, S., Lindenbach, B.D., Chien, M., Weir, D.B., Russo, J.J., Ju, J., Brownstein, M.J., Sheridan, R., Sander, C., Zavolan, M., Tuschl, T., Rice, C.M., Cellular cofactors affecting hepatitis C virus infection and replication. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 12884–12889.
79. Rao, S.A., Santosh, V., Somasundaram, K., Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod. Pathol. 23 (2010), 1404–1417.
80. Reed, L.J., Muench, H., A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27 (1938), 493–497.
81. Reymond, N., Fabre, S., Lecocq, E., Adelaide, J., Dubreuil, P., Lopez, M., Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with Nectin1/PRR1 through V domain interaction. J. Biol. Chem. 276 (2001), 43205–43215.
82. Schaefer, A., Jung, M., Mollenkopf, H.J., Wagner, I., Stephan, C., Jentzmik, F., Miller, K., Lein, M., Kristiansen, G., Jung, K., Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int. J. Cancer 126 (2010), 1166–1176.
83. Schneider-Schaulies, J., Schnorr, J.J., Brinckmann, U., Dunster, L.M., Baczko, K., Liebert, U.G., Schneider-Schaulies, S., Ter Meulen, V., Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 3943–3947.
84. Shi, Z.M., Wang, J., Yan, Z., You, Y.P., Li, C.Y., Qian, X., Yin, Y., Zhao, P., Wang, Y.Y., Wang, X.F., Li, M.N., Liu, L.Z., Liu, N., Jiang, B.H., MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1. PLoS One, 7, 2012, e32709.
85. Skalsky, R.L., Cullen, B.R., Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene. PLoS One, 6, 2011, e24248.
86. Sugiyama, T., Yoneda, M., Kuraishi, T., Hattori, S., Inoue, Y., Sato, H., Kai, C., Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment. Gene Ther. 20 (2013), 338–347.
87. Takahashi, Y., Iwaya, T., Sawada, G., Kurashige, J., Matsumura, T., Uchi, R., Ueo, H., Takano, Y., Eguchi, H., Sudo, T., Sugimachi, K., Yamamoto, H., Doki, Y., Mori, M., Mimori, K., Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer. Ann. Surg. Oncol. 21 (2014), 205–212.
88. Tatsuo, H., Ono, N., Tanaka, K., Yanagi, Y., SLAM (CDw150) is a cellular receptor for measles virus. Nature 406 (2000), 893–897.
89. tenOever, B.R., RNA viruses and the host microRNA machinery. Nat. Rev. Microbiol. 11 (2013), 169–180.
90. Untergasser, A., Cutcutache, I., Koressaar, T., Ye, J., Faircloth, B.C., Remm, M., Rozen, S.G., Primer3–new capabilities and interfaces. Nucleic Acids Res., 40, 2012, e115.
91. Usvasalo, A., Ninomiya, S., Raty, R., Hollmen, J., Saarinen-Pihkala, U.M., Elonen, E., Knuutila, S., Focal 9p instability in hematologic neoplasias revealed by comparative genomic hybridization and single-nucleotide polymorphism microarray analyses. Genes Chromosomes Cancer 49 (2010), 309–318.
92. van Rooij, E., The art of microRNA research. Circ. Res. 108 (2011), 219–234.
93. Veerla, S., Lindgren, D., Kvist, A., Frigyesi, A., Staaf, J., Persson, H., Liedberg, F., Chebil, G., Gudjonsson, S., Borg, A., Mansson, W., Rovira, C., Hoglund, M., MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. Int. J. Cancer 124 (2009), 2236–2242.
94. Vire, E., Curtis, C., Davalos, V., Git, A., Robson, S., Villanueva, A., Vidal, A., Barbieri, I., Aparicio, S., Esteller, M., Caldas, C., Kouzarides, T., The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31. Mol. Cell 53 (2014), 806–818.
95. Visani, M., de Biase, D., Marucci, G., Cerasoli, S., Nigrisoli, E., Bacchi Reggiani, M.L., Albani, F., Baruzzi, A., Pession, A., Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III. Mol. Oncol. 8 (2014), 417–430.
96. Volinia, S., Calin, G.A., Liu, C.G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., Prueitt, R.L., Yanaihara, N., Lanza, G., Scarpa, A., Vecchione, A., Negrini, M., Harris, C.C., Croce, C.M., A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 2257–2261.
97. Weiss, G.J., Bemis, L.T., Nakajima, E., Sugita, M., Birks, D.K., Robinson, W.A., Varella-Garcia, M., Bunn, P.A. Jr., Haney, J., Helfrich, B.A., Kato, H., Hirsch, F.R., Franklin, W.A., EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann. Oncol. 19 (2008), 1053–1059.
98. Welstead, G.G., Hsu, E.C., Iorio, C., Bolotin, S., Richardson, C.D., Mechanism of CD150 (SLAM) down regulation from the host cell surface by measles virus hemagglutinin protein. J. Virol. 78 (2004), 9666–9674.
99. Woo, H.H., Laszlo, C.F., Greco, S., Chambers, S.K., Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152. Mol. Cancer, 11, 2012, 58.
100. Wszolek, M.F., Rieger-Christ, K.M., Kenney, P.A., Gould, J.J., Silva Neto, B., Lavoie, A.K., Logvinenko, T., Libertino, J.A., Summerhayes, I.C., A MicroRNA expression profile defining the invasive bladder tumor phenotype. Urol. Oncol. 29 (2011), 794–801 e791.
101. Wu, C., Lin, J., Hong, M., Choudhury, Y., Balani, P., Leung, D., Dang, L.H., Zhao, Y., Zeng, J., Wang, S., Combinatorial control of suicide gene expression by tissue-specific promoter and microRNA regulation for cancer therapy. Mol. Ther. 17 (2009), 2058–2066.
102. Wyman, S.K., Parkin, R.K., Mitchell, P.S., Fritz, B.R., O'Briant, K., Godwin, A.K., Urban, N., Drescher, C.W., Knudsen, B.S., Tewari, M., Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS One, 4, 2009, e5311.
103. Yan, L.X., Huang, X.F., Shao, Q., Huang, M.Y., Deng, L., Wu, Q.L., Zeng, Y.X., Shao, J.Y., MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14 (2008), 2348–2360.
104. Yang, D., Sun, Y., Hu, L., Zheng, H., Ji, P., Pecot, C.V., Zhao, Y., Reynolds, S., Cheng, H., Rupaimoole, R., Cogdell, D., Nykter, M., Broaddus, R., Rodriguez-Aguayo, C., Lopez-Berestein, G., Liu, J., Shmulevich, I., Sood, A.K., Chen, K., Zhang, W., Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell 23 (2013), 186–199.
105. Yao, W.C., Guo, G.C., Zhang, Q.Q., Fan, L.Y., Wu, N., Bo, Y.L., The application of multiple miRNA response elements enables oncolytic adenoviruses to possess specificity to glioma cells. Virology 458 (2014), 69–82.
106. Zhang, L., Huang, J., Yang, N., Greshock, J., Megraw, M.S., Giannakakis, A., Liang, S., Naylor, T.L., Barchetti, A., Ward, M.R., Yao, G., Medina, A., O'Brien-Jenkins, A., Katsaros, D., Hatzigeorgiou, A., Gimotty, P.A., Weber, B.L., Coukos, G., MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 9136–9141.
107. Zhang, Y., Chao, T., Li, R., Liu, W., Chen, Y., Yan, X., Gong, Y., Yin, B., Qiang, B., Zhao, J., Yuan, J., Peng, X., MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J. Mol. Med. (Berl) 87 (2009), 43–51.
108. Zhang, Y., Guo, J., Li, D., Xiao, B., Miao, Y., Jiang, Z., Zhuo, H., Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance. Med. Oncol. 27 (2010), 685–689.
109. Zhang, Z.W., Zhang, X.M., Newman, K., Liu, X.Y., MicroRNA regulation of oncolytic adenovirus 6 for selective treatment of castration-resistant prostate cancer. Mol. Cancer Ther. 11 (2012), 2410–2418.
110. Zipprich, J., Winter, K., Hacker, J., Xia, D., Watt, J., Harriman, K., Measles outbreak–California, December 2014-February 2015. MMWR Morb. Mortal. Wkly. Rep. 64 (2015), 153–154.
111. Zygiert, Z., Hodgkin's disease: remissions after measles. Lancet, 1, 1971, 593.